Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
NCT06305949

Clinical Trial on the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Swallowing Function in Patients With Post-Stroke Dysphagia

Led by NEUROPHET · Updated on 2026-04-09

30

Participants Needed

1

Research Sites

114 weeks

Total Duration

On this page

Sponsors

N

NEUROPHET

Lead Sponsor

B

Bucheon St. Mary's Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to evaluate whether the application of optimized transcranial direct current stimulation is more effective compared to sham stimulation for temporary improvement of swallowing function in patients with post-stroke dysphagia.

CONDITIONS

Official Title

Clinical Trial on the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Swallowing Function in Patients With Post-Stroke Dysphagia

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women older than 19 years
  • Patients with stroke confirmed by neuroimaging
  • First-time stroke patients
  • Patients 3 weeks or more after stroke onset in subacute or chronic phase
  • Stroke patients with confirmed dysphagia by Videofluoroscopic Swallowing Study (VFSS)
Not Eligible

You will not qualify if you...

  • Patients with recurrent stroke, traumatic brain injury, spinal cord injury, or degenerative brain diseases such as Parkinson's disease
  • Patients with deteriorated cognitive function unable to follow trial instructions
  • Patients with delirium, confusion, or impaired consciousness
  • Patients with uncontrolled medical or surgical conditions
  • Patients ineligible for transcranial direct current stimulation due to scalp condition, metallic materials near electrode area, pacemaker, or cochlear implant
  • Patients who have used similar stimulation devices in the last year or participated in related trials
  • Patients with severe neurologic disorders and major psychiatric disorders such as major depression or dementia
  • Patients with uncontrolled epilepsy within the past 6 months
  • Patients with contraindications for neuroimaging tests like MRI
  • Patients taking contraindicated medications or needing medication changes affecting brain function during the trial
  • Patients who are pregnant, breastfeeding, or planning pregnancy during the trial
  • Patients medically ineligible for the trial for reasons beyond the criteria listed

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Catholic University of Korea, Bucheon St. Mary's Hospital

Bucheon-si, South Korea, 14647

Actively Recruiting

Loading map...

Research Team

T

TaeYeong Kim

CONTACT

S

Seungeun Lee

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here